世界の季節性インフルエンザワクチン治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Seasonal Influenza Vaccines Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z12326 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥504,600 (USD3,480)	▷ お問い合わせ
Multi User	￥756,900 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,009,200 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、季節性インフルエンザワクチン治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。季節性インフルエンザワクチン治療薬の種類別市場規模（小児、青年、成人、高齢者）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・季節性インフルエンザワクチン治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GSK、Novartis、CSL、MedImmune、Sanofi-Pasteur、Solvay、Sinovac Biotech、Hualun Biologicals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：小児、青年、成人、高齢者 ・用途別分析2016年-2026年：病院、診療所、その他 ・季節性インフルエンザワクチン治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・季節性インフルエンザワクチン治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・季節性インフルエンザワクチン治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・季節性インフルエンザワクチン治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・季節性インフルエンザワクチン治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Seasonal Influenza Vaccines Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Seasonal Influenza Vaccines Therapeutics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Seasonal Influenza Vaccines Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Seasonal Influenza Vaccines Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Paediatrics
Adolescence
Adults
Elderly

Market segment by Application, can be divided into
Hospitals
Clinics
Others

Market segment by players, this report covers
GSK
Novartis
CSL
MedImmune
Sanofi-Pasteur
Solvay
Sinovac Biotech
Hualun Biologicals

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Seasonal Influenza Vaccines Therapeutics
1.2 Classification of Seasonal Influenza Vaccines Therapeutics by Type
1.2.1 Overview: Global Seasonal Influenza Vaccines Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type in 2020
1.2.3 Paediatrics
1.2.4 Adolescence
1.2.5 Adults
1.2.6 Elderly
1.3 Global Seasonal Influenza Vaccines Therapeutics Market by Application
1.3.1 Overview: Global Seasonal Influenza Vaccines Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Seasonal Influenza Vaccines Therapeutics Market Size & Forecast
1.5 Global Seasonal Influenza Vaccines Therapeutics Market Size and Forecast by Region
1.5.1 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Seasonal Influenza Vaccines Therapeutics Market Drivers
1.6.2 Seasonal Influenza Vaccines Therapeutics Market Restraints
1.6.3 Seasonal Influenza Vaccines Therapeutics Trends Analysis
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.1.4 GSK Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GSK Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.2.4 Novartis Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.3.4 CSL Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 CSL Recent Developments and Future Plans
2.4 MedImmune
2.4.1 MedImmune Details
2.4.2 MedImmune Major Business
2.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.4.4 MedImmune Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 MedImmune Recent Developments and Future Plans
2.5 Sanofi-Pasteur
2.5.1 Sanofi-Pasteur Details
2.5.2 Sanofi-Pasteur Major Business
2.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.5.4 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sanofi-Pasteur Recent Developments and Future Plans
2.6 Solvay
2.6.1 Solvay Details
2.6.2 Solvay Major Business
2.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.6.4 Solvay Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Solvay Recent Developments and Future Plans
2.7 Sinovac Biotech
2.7.1 Sinovac Biotech Details
2.7.2 Sinovac Biotech Major Business
2.7.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.7.4 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Sinovac Biotech Recent Developments and Future Plans
2.8 Hualun Biologicals
2.8.1 Hualun Biologicals Details
2.8.2 Hualun Biologicals Major Business
2.8.3 Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.8.4 Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Hualun Biologicals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Seasonal Influenza Vaccines Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Seasonal Influenza Vaccines Therapeutics Players Market Share
3.2.2 Top 10 Seasonal Influenza Vaccines Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Seasonal Influenza Vaccines Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Seasonal Influenza Vaccines Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Seasonal Influenza Vaccines Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Seasonal Influenza Vaccines Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Seasonal Influenza Vaccines Therapeutics Revenue by Type (2016-2026)
6.2 North America Seasonal Influenza Vaccines Therapeutics Revenue by Application (2016-2026)
6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country
6.3.1 North America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Seasonal Influenza Vaccines Therapeutics Revenue by Type (2016-2026)
7.2 Europe Seasonal Influenza Vaccines Therapeutics Revenue by Application (2016-2026)
7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country
7.3.1 Europe Seasonal Influenza Vaccines Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region
8.3.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Region (2016-2026)
8.3.2 China Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Seasonal Influenza Vaccines Therapeutics Revenue by Type (2016-2026)
9.2 South America Seasonal Influenza Vaccines Therapeutics Revenue by Application (2016-2026)
9.3 South America Seasonal Influenza Vaccines Therapeutics Market Size by Country
9.3.1 South America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country
10.3.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Seasonal Influenza Vaccines Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Seasonal Influenza Vaccines Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Seasonal Influenza Vaccines Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. GSK Corporate Information, Head Office, and Major Competitors
Table 7. GSK Major Business
Table 8. GSK Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 9. GSK Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 13. Novartis Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. CSL Corporate Information, Head Office, and Major Competitors
Table 15. CSL Major Business
Table 16. CSL Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 17. CSL Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. MedImmune Corporate Information, Head Office, and Major Competitors
Table 19. MedImmune Major Business
Table 20. MedImmune Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 21. MedImmune Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sanofi-Pasteur Corporate Information, Head Office, and Major Competitors
Table 23. Sanofi-Pasteur Major Business
Table 24. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 25. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Solvay Corporate Information, Head Office, and Major Competitors
Table 27. Solvay Major Business
Table 28. Solvay Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 29. Solvay Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Sinovac Biotech Corporate Information, Head Office, and Major Competitors
Table 31. Sinovac Biotech Major Business
Table 32. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 33. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Hualun Biologicals Corporate Information, Head Office, and Major Competitors
Table 35. Hualun Biologicals Major Business
Table 36. Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 37. Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 39. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Players (2019-2021)
Table 40. Breakdown of Seasonal Influenza Vaccines Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Seasonal Influenza Vaccines Therapeutics Players Head Office, Products and Services Provided
Table 42. Seasonal Influenza Vaccines Therapeutics Mergers & Acquisitions in the Past Five Years
Table 43. Seasonal Influenza Vaccines Therapeutics New Entrants and Expansion Plans
Table 44. Global Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 45. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Type (2016-2021)
Table 46. Global Seasonal Influenza Vaccines Therapeutics Revenue Forecast by Type (2021-2026)
Table 47. Global Seasonal Influenza Vaccines Therapeutics Revenue by Application (2016-2021)
Table 48. Global Seasonal Influenza Vaccines Therapeutics Revenue Forecast by Application (2021-2026)
Table 49. North America Seasonal Influenza Vaccines Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Seasonal Influenza Vaccines Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Seasonal Influenza Vaccines Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Seasonal Influenza Vaccines Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Seasonal Influenza Vaccines Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Seasonal Influenza Vaccines Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Seasonal Influenza Vaccines Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Seasonal Influenza Vaccines Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Seasonal Influenza Vaccines Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Seasonal Influenza Vaccines Therapeutics Picture
Figure 2. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type in 2020
Figure 3. Paediatrics
Figure 4. Adolescence
Figure 5. Adults
Figure 6. Elderly
Figure 7. Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Others Picture
Figure 11. Global Seasonal Influenza Vaccines Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Seasonal Influenza Vaccines Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Region (2016-2026)
Figure 14. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Region in 2020
Figure 15. North America Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Seasonal Influenza Vaccines Therapeutics Market Drivers
Figure 20. Seasonal Influenza Vaccines Therapeutics Market Restraints
Figure 21. Seasonal Influenza Vaccines Therapeutics Market Trends
Figure 22. GSK Recent Developments and Future Plans
Figure 23. Novartis Recent Developments and Future Plans
Figure 24. CSL Recent Developments and Future Plans
Figure 25. MedImmune Recent Developments and Future Plans
Figure 26. Sanofi-Pasteur Recent Developments and Future Plans
Figure 27. Solvay Recent Developments and Future Plans
Figure 28. Sinovac Biotech Recent Developments and Future Plans
Figure 29. Hualun Biologicals Recent Developments and Future Plans
Figure 31. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Players in 2020
Figure 32. Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Seasonal Influenza Vaccines Therapeutics Revenue Market Share in 2020
Figure 34. Global Top 10 Players Seasonal Influenza Vaccines Therapeutics Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Type in 2020
Figure 37. Global Seasonal Influenza Vaccines Therapeutics Market Share Forecast by Type (2021-2026)
Figure 38. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Application in 2020
Figure 39. Global Seasonal Influenza Vaccines Therapeutics Market Share Forecast by Application (2021-2026)
Figure 40. North America Seasonal Influenza Vaccines Therapeutics Sales Market Share by Type (2016-2026)
Figure 41. North America Seasonal Influenza Vaccines Therapeutics Sales Market Share by Application (2016-2026)
Figure 42. North America Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Country (2016-2026)
Figure 43. United States Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Seasonal Influenza Vaccines Therapeutics Sales Market Share by Type (2016-2026)
Figure 47. Europe Seasonal Influenza Vaccines Therapeutics Sales Market Share by Application (2016-2026)
Figure 48. Europe Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Country (2016-2026)
Figure 49. Germany Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Region (2016-2026)
Figure 57. China Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Seasonal Influenza Vaccines Therapeutics Sales Market Share by Type (2016-2026)
Figure 64. South America Seasonal Influenza Vaccines Therapeutics Sales Market Share by Application (2016-2026)
Figure 65. South America Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source

---